8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine has been researched along with mrs 1754 in 4 studies
| Studies (8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine) | Trials (8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine) | Recent Studies (post-2010) (8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine) | Studies (mrs 1754) | Trials (mrs 1754) | Recent Studies (post-2010) (mrs 1754) |
|---|---|---|---|---|---|
| 16 | 0 | 3 | 30 | 0 | 13 |
| Protein | Taxonomy | 8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine (IC50) | mrs 1754 (IC50) |
|---|---|---|---|
| Adenosine receptor A2a | Homo sapiens (human) | 1 | |
| Adenosine receptor A2b | Homo sapiens (human) | 0.032 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobson, KA; Ji, X; Kim, YC; Linden, J; Melman, N | 1 |
| Ahern, DG; Jacobson, KA; Ji, X; Kim, YC; Linden, J | 1 |
| Jacobson, KA; Kim, HS; Kim, SA; Linden, J; Marshall, MA; Melman, N; Müller, CE | 1 |
| Cadavid, MI; Carotti, A; Centeno, NB; Esteve, C; Loza, MI; Martinez, A; Nieto, R; Raviña, E; Sanz, F; Segarra, V; Sotelo, E; Stefanachi, A; Vidal, B | 1 |
4 other study(ies) available for 8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine and mrs 1754
| Article | Year |
|---|---|
Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.
Topics: Anilides; Animals; Calcium; Cell Line; Humans; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptor, Adenosine A3; Receptors, Purinergic P1; Structure-Activity Relationship; Xanthines | 2000 |
[3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.
Topics: Acetamides; Cells, Cultured; Humans; Purinergic P1 Receptor Antagonists; Purines; Radioligand Assay; Radiopharmaceuticals; Receptor, Adenosine A2B; Tritium | 2001 |
Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
Topics: Animals; Binding, Competitive; Cell Line; Cloning, Molecular; Humans; Ligands; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship; Xanthines | 2002 |
Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Antagonists; Animals; Binding, Competitive; Cell Line; CHO Cells; Cricetinae; Drug Design; HeLa Cells; Humans; Molecular Structure; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Xanthines | 2006 |